Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial2008· article· en· The Lancet· Medicineaffno abstract1,588citations
Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases2003· article· en· Journal of Clinical Investigation· Medicineafffund1,278citations
Pre-eclampsia: pathophysiology and clinical implications2019· review· en· BMJ· Medicineaff1,219citations
Relation Between Kidney Function, Proteinuria, and Adverse Outcomes2010· article· en· JAMA· Medicineafffundabout1,032citations
Bevacizumab Plus Interferon Alfa Compared With Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: CALGB 902062008· article· en· Journal of Clinical Oncology· Medicineaff908citations
Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data2015· review· en· The Lancet Diabetes & Endocrinology· Medicineaffno abstract897citations
Focal Segmental Glomerulosclerosis2011· review· en· New England Journal of Medicine· Medicineaff813citations
APOL1 Risk Variants, Race, and Progression of Chronic Kidney Disease2013· article· en· New England Journal of Medicine· Medicineaff784citations
Cause of Death in Patients with Reduced Kidney Function2015· article· en· Journal of the American Society of Nephrology· Medicineafffundabout652citations
The frequency and outcome of lupus nephritis: results from an international inception cohort study2015· article· en· Lara D. Veeken· Medicineaff632citations
Remission of Proteinuria Improves Prognosis in IgA Nephropathy2007· article· en· Journal of the American Society of Nephrology· Medicineafffundabout630citations
Early recognition and prevention of chronic kidney disease2010· review· en· The Lancet· Medicineaffno abstract604citations
Idiopathic nephrotic syndrome in children2018· review· en· The Lancet· Medicineaffno abstract578citations
Agalsidase-Beta Therapy for Advanced Fabry Disease2007· article· en· Annals of Internal Medicine· Medicineaff566citations
Effect of fetal and child health on kidney development and long-term risk of hypertension and kidney disease2013· review· en· The Lancet· Medicineaffno abstract553citations
Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy2017· article· en· JAMA· Medicineafffund530citations
Endoplasmic reticulum stress, the unfolded protein response and autophagy in kidney diseases2017· review· en· Nature Reviews Nephrology· Biochemistry, Genetics and Molecular Biologyaffno abstract522citations
Modification of kidney barrier function by the urokinase receptor2007· article· en· Nature Medicine· Medicineaffno abstract520citations
Long-term Renal Prognosis of Diarrhea-Associated Hemolytic Uremic Syndrome2003· review· en· JAMA· Immunology and Microbiologyaff515citations
Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments2014· article· en· Kidney International· Medicineaff496citations
Statins for Improving Renal Outcomes2006· review· en· Journal of the American Society of Nephrology· Medicineaff480citations
Evaluating a New International Risk-Prediction Tool in IgA Nephropathy2019· article· en· JAMA Internal Medicine· Medicineafffund475citations
Rituximab-Induced Depletion of Anti-PLA2R Autoantibodies Predicts Response in Membranous Nephropathy2011· article· en· Journal of the American Society of Nephrology· Medicineaff468citations